Skip to main content

Alan Glicklich, M.D.

Equibles does not estimate personal net worth.

Get an email with a short summary when CalciMedica, Inc. publishes a filing, an earnings call transcript or a press release.

Get CALC alerts

About Alan Glicklich, M.D.

Alan Glicklich, M.D. is recorded as Board Member at CalciMedica, Inc. (CALC) since January 13, 2025. CalciMedica, Inc. reported in an 8-K filed January 14, 2025 that Alan Glicklich, M.D. was appointed Class I director, effective January 15, 2025. CalciMedica, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CalciMedica, Inc. includes A. Rachel Leheny (CEO and Board Member), A. Rachel Leheny, Ph.D. (CEO and Board Member), Ann Rachel Leheny (CEO) and 7 others.

“On January 13, 2025, the Company’s Board appointed Alan Glicklich, M.D., as a Class I director of the Company, effective as of the Effective Date, with a term of office expiring at the 2027 annual meeting of stockholders.”
CalciMedica, Inc. Form 8-K, filed January 14, 2025 · Read the filing

Affiliation history

Company network

Current role

Biotechnology · Healthcare

Board Member

2025-01-13–present

Leadership on record at CalciMedica, Inc.

Recent activity